Flock, smart-money disclosures made readable

Flock, smart-money disclosures made readable

Show all 41 disclosures

DISCLOSEDQuarterly
Dodge & Cox
Regeneron Pharmaceuticals · NASDAQ
4,871,137 sh · $3.04B
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Bridgewater Associates
Regeneron Pharmaceuticals · NASDAQ
51,333 sh · $32.0M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDQuarterly
Two Sigma Investments
Regeneron Pharmaceuticals · NASDAQ
656,124 sh · $409.1M
Filed 30 Jun 2026SEC 13Fview source
DISCLOSEDStale
Dodge & Cox
Regeneron Pharmaceuticals · NASDAQ
4,458,238 sh · $3.44B
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Bridgewater Associates
Regeneron Pharmaceuticals · NASDAQ
22,724 sh · $17.6M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Regeneron Pharmaceuticals · NASDAQ
66,802 sh · $51.6M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
Regeneron Pharmaceuticals · NASDAQ
8,947,735 sh · $6.91B
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
Regeneron Pharmaceuticals · NASDAQ
812,236 sh · $627.6M
Filed 31 Mar 2026SEC 13Fview source
DISCLOSEDStale
BlackRock
Regeneron Pharmaceuticals · NASDAQ
8,741,270 sh · $6.75B
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
Regeneron Pharmaceuticals · NASDAQ
281,151 sh · $217.0M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Dodge & Cox
Regeneron Pharmaceuticals · NASDAQ
4,596,358 sh · $3.55B
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
ARK Investment Management
Regeneron Pharmaceuticals · NASDAQ
110 sh · $84.7K
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Bridgewater Associates
Regeneron Pharmaceuticals · NASDAQ
72,745 sh · $56.1M
Filed 31 Dec 2025SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
Regeneron Pharmaceuticals · NASDAQ
469,903 sh · $264.2M
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
Dodge & Cox
Regeneron Pharmaceuticals · NASDAQ
4,550,845 sh · $2.56B
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
Bridgewater Associates
Regeneron Pharmaceuticals · NASDAQ
235,381 sh · $132.3M
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
BlackRock
Regeneron Pharmaceuticals · NASDAQ
8,837,174 sh · $4.97B
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
Renaissance Technologies
Regeneron Pharmaceuticals · NASDAQ
275,162 sh · $154.7M
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
ARK Investment Management
Regeneron Pharmaceuticals · NASDAQ
12,142 sh · $6.8M
Filed 30 Sept 2025SEC 13Fview source
DISCLOSEDStale
ARK Investment Management
Regeneron Pharmaceuticals · NASDAQ
12,606 sh · $6.6M
Filed 30 Jun 2025SEC 13Fview source
DISCLOSEDStale
Two Sigma Investments
Regeneron Pharmaceuticals · NASDAQ
499,828 sh · $262.4M
Filed 30 Jun 2025SEC 13Fview source
DISCLOSEDStale
Dodge & Cox
Regeneron Pharmaceuticals · NASDAQ
3,826,283 sh · $2.01B
Filed 30 Jun 2025SEC 13Fview source
DISCLOSEDStale
Scion Asset Management
Regeneron Pharmaceuticals · NASDAQ
215,000 sh · $112.9M
Filed 30 Jun 2025SEC 13Fview source
DISCLOSEDStale
BlackRock
Regeneron Pharmaceuticals · NASDAQ
9,277,085 sh · $4.87B
Filed 30 Jun 2025SEC 13Fview source
DISCLOSEDStale
Bridgewater Associates
Regeneron Pharmaceuticals · NASDAQ
89,047 sh · $46.7M
Filed 30 Jun 2025SEC 13Fview source
DISCLOSEDStale
BlackRock
Regeneron Pharmaceuticals · NASDAQ
8,925,880 sh · $5.66B
Filed 31 Mar 2025SEC 13Fview source
DISCLOSEDStale
BlackRock
Regeneron Pharmaceuticals · NASDAQ
8,731,622 sh · $6.22B
Filed 31 Dec 2024SEC 13Fview source
DISCLOSEDStale
BlackRock
Regeneron Pharmaceuticals · NASDAQ
8,480,262 sh · $8.91B
Filed 30 Sept 2024SEC 13Fview source
DISCLOSEDStale
BlackRock
Regeneron Pharmaceuticals · NASDAQ
8,446,366 sh · $8.88B
Filed 30 Jun 2024SEC 13Fview source
DISCLOSEDStale
BlackRock
Regeneron Pharmaceuticals · NASDAQ
8,568,654 sh · $8.25B
Filed 31 Mar 2024SEC 13Fview source
DISCLOSEDStale
BlackRock
Regeneron Pharmaceuticals · NASDAQ
8,629,707 sh · $7.58B
Filed 31 Dec 2023SEC 13Fview source